June 26 (Reuters) - Ascendis Pharma A/S ASND.O
* Ascendis Pharma - initiated regulatory submissions in australia to enable co's entry into its first human clinical study with transcon parathyroid hormone Source text for Eikon: ID:nEOLYyBVy Further company coverage: ASND.O